Zilong Zhao

4PUBLICATIONS
57CO-AUTHORS
Molecular targetsCell metabolismApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 20, 2026
Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma.

|Aug 15, 2024
LIFR regulates cholesterol-driven bidirectional hepatocyte-neutrophil cross-talk to promote liver regeneration.

Yalan Deng, Zilong Zhao, Marisela Sheldon

|Feb 01, 2023
Tumor-associated nonmyelinating Schwann cell-expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion.

Chengcao Sun, Youqiong Ye, Zhi Tan

|Nov 02, 2022
Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditis.

Yaohua Zhang, Chengcao Sun, Yajuan Li

Pageof 1

Frequent Collaborators

4 joint publications

Chunru Lin

3 joint publications

Liuqing Yang

3 joint publications

Michael A Curran

2 joint publications

Chengcao Sun